EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Review of Preclinical and Clinical Studies Supporting the Role of Polydeoxyribonucleotide in the Treatment of Tendon Disorders

Shengyu Luo, Shilin Huang, Sen Li

Medical Science Monitor · 2025

DOI: 10.12659/msm.945743 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Shengyu Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Physical Education, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: Polydeoxyribonucleotides, Tendinopathy, Tendon Injuries. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolydeoxyribonucleotidesTendinopathyTendon InjuriesHumansAnimalsTendonsWound Healing

Substanzen

Polydeoxyribonucleotides

Autor:innen und Institutionen

  • School of Physical Education, Southwest Medical University, Luzhou, Sichuan, China.
  • Division of Spine Surgery, Department of Orthopedic Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.

Zitieren

APA

Luo, S., Huang, S., & Li, S. (2025). Review of Preclinical and Clinical Studies Supporting the Role of Polydeoxyribonucleotide in the Treatment of Tendon Disorders. Medical Science Monitor. https://doi.org/10.12659/msm.945743

Vancouver

Luo S, Huang S, Li S. Review of Preclinical and Clinical Studies Supporting the Role of Polydeoxyribonucleotide in the Treatment of Tendon Disorders. Medical Science Monitor. 2025. doi:10.12659/msm.945743

BibTeX
@article{Luo2025,
  author = {Luo, Shengyu and Huang, Shilin and Li, Sen},
  title = {Review of Preclinical and Clinical Studies Supporting the Role of Polydeoxyribonucleotide in the Treatment of Tendon Disorders},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.945743}
}
Kostenlos starten →